1. Home
  2. HQL

HQL

abrdn Life Sciences Investors Shares of Beneficial Interest

Logo abrdn Life Sciences Investors Shares of Beneficial Interest

Finance

Investment Managers

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing primarily in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have significant potential for above-average growth.

Founded: 1992 Country:
United States
United States
Employees: N/A City: N/A
Market Cap: 355.0M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 120.9K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: 11.56% Dividend Payout Frequency: Quarterly
EPS: 0.79 EPS Growth: N/A
52 Week Low/High: $11.34 - $14.37 Next Earning Date: 01-01-0001
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: